Dr. Phillips is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3737 Market St
3rd Floor
Philadelphia, PA 19104Phone+1 215-662-2775- Is this information wrong?
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 1969 - 1972
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1966 - 1969
- University of Wisconsin School of Medicine & Public HealthClass of 1966
Certifications & Licensure
- PA State Medical License 1975 - 2022
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1980
Publications & Presentations
PubMed
- 1 citationsIs oral isotretinoin treatment contraindicated for patients with known peanut allergiesVictoria S. Humphrey, S. Michael Phillips, William D. James> ;JAAD Case Reports. 2020 Jan 16
- 1 citationsDAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice.Mahendra K. Bhopale, Brendan Hilliard, Cris S. Constantinescu, S. Michael Phillips, Abdolmohamad Rostami> ;Immunopharmacology and Immunotoxicology. 2017 Sep 20
- 3 citationsDAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.Mahendra K. Bhopale, Brendan Hilliard, Cris S. Constantinescu, Toshiki Fujioka, Elvira Ventura, S. Michael Phillips, Abdolmohamad Rostami> ;Experimental and Molecular Pathology. 2014 Feb 1
- Join now to see all
Grant Support
- Suppression Of Immunopathology In Schistosmiasis By AntiNational Institute Of Allergy And Infectious Diseases2000–2001
- S Mansoni Vitellogenesis And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1996–1999
- Suppression Of Immunopathology In Schistosomiasis By DABNational Institute Of Allergy And Infectious Diseases1994–1997
- S. Mansoni Vitellogenesis And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1989–1993
- S. Mansoni Vitellogenesis And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1989–1991
- In Vitro S. Mansoni Fecundity And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1985–1988
- The Idiotypic Regulation Of Resistance To SchistosomiasiNational Institute Of Allergy And Infectious Diseases1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: